CLL Trials Updates from European Haematology Association Meeting 2019

[Jm954]

Patrick Thornton, MD, Beaumont Hospital, Dublin, Ireland, tells us about some of the excellent CLL updates presented at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam.

Dr Thornton discusses a variety of updates, such as bringing novel agents into the frontline setting and reducing the use of chemotherapy, which tends to have more issues with toxicity. The iLLUMINATE, VISION, MURANO CLL12, CLL14, CLL17, studies are also mentioned (NCT02264574, NCT03226301, NCT02005471, NCT02863718, NCT02242942).

youtube.com/watch?v=2a72Prb...(Not working as expected?)

Jackie

[SethB34]

Nice, concise stuff.

[Irishcll]

Thanks for sharing Jackie.

Patients in Ireland are limited in access to trials but we will have CLL 17 take place next year .

This will be a chemo free trial.

Regards

Michael

[Jm954 Administrator in reply to Irishcll]

A bit of information here about CLL17 healthunlocked.com/cllsuppo....

Jackie

[Wroxham]

Thank you Jackie. Very precise and informative.

Sue